Form 4: Singular Genomics Systems Executive Glezer Eli N. Reports Stock Transactions
SEC Form 4
Eli N. Glezer, Chief Scientific Officer of Singular Genomics Systems, reports the acquisition and disposal of common stock and derivative securities.
Summary
- On February 9, 2025, Eli N. Glezer, Chief Scientific Officer of Singular Genomics Systems, reported transactions involving the company's stock.
- Glezer acquired 500 shares of Common Stock through the settlement of vested Restricted Stock Units (RSUs).
- Following the reported transactions, Glezer beneficially owns 155,583 shares of Common Stock.
- Glezer also disposed of 500 Restricted Stock Units.
- The RSUs vest in 16 equal quarterly installments over four years, starting from February 9, 2024.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by an officer, with no inherent positive or negative implications.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock. It allows investors to monitor the actions of key personnel and their alignment with the company's performance.
Stakeholder Impact
- Shareholders can monitor insider transactions to gain insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 02/09/2024 | Start date for RSU vesting, which occurs in 16 equal quarterly installments over four years. |
| 02/09/2025 | Date of the reported stock transactions, including acquisition of common stock and disposal of RSUs. |
| 02/11/2025 | Date of signature for the Form 4 filing. |
Keywords
Singular Genomics Systems, Glezer Eli N., Form 4, Stock Transactions, Restricted Stock Units, Beneficial Ownership, Officer, OMIC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.